Diamonds and Dogs

6/18/20

PayPal (PYPL) higher on an upgrade. The digital payment platform stock is up a percent to new highs as the analyst at Robert W. Baird reiterated an outperform rating with $175 price target after boosting revenue and earnings per share estimates. Covid-19 has accelerated the move to more digital payment systems.Paypal's stock is up 80% from the March lows.

Biogen (BIIB) lower following a court battle. The biotech is down 5% to a nine-month low after the U.S. district court judge ruled in favor of the generic drug maker, Mylan regarding the patent for Biogen's booming multiple sclerosis drug Tecfidera. Tecfidera has powered much of Biogen's growth since its launch seven years ago. The drug produced sales of $4.43 billion last year, making up almost one-third of the company's revenue.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.